Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease

Fructose is one of the key dietary catalysts in the development of non-alcoholic fatty liver disease (NAFLD). NAFLD comprises a complex disease spectrum, including steatosis (fatty liver), non-alcoholic steatohepatitis, hepatocyte injury, inflammation, and fibrosis. It is also the hepatic manifestat...

Full description

Bibliographic Details
Main Authors: Jessica Lambertz, Sabine Weiskirchen, Silvano Landert, Ralf Weiskirchen
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01159/full
id doaj-f1ec86a3ce114ab29e62e26aee337816
record_format Article
spelling doaj-f1ec86a3ce114ab29e62e26aee3378162020-11-24T23:13:04ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-09-01810.3389/fimmu.2017.01159295235Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver DiseaseJessica Lambertz0Sabine Weiskirchen1Silvano Landert2Ralf Weiskirchen3Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, GermanyInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, GermanyCulture Collection of Switzerland AG (CCOS), Wädenswil, SwitzerlandInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, GermanyFructose is one of the key dietary catalysts in the development of non-alcoholic fatty liver disease (NAFLD). NAFLD comprises a complex disease spectrum, including steatosis (fatty liver), non-alcoholic steatohepatitis, hepatocyte injury, inflammation, and fibrosis. It is also the hepatic manifestation of the metabolic syndrome, which covers abdominal obesity, insulin resistance, dyslipidemia, glucose intolerance, or type 2 diabetes mellitus. Commensal bacteria modulate the host immune system, protect against exogenous pathogens, and are gatekeepers in intestinal barrier function and maturation. Dysbalanced intestinal microbiota composition influences a variety of NAFLD-associated clinical conditions. Conversely, nutritional supplementation with probiotics and preobiotics impacting composition of gut microbiota can improve the outcome of NAFLD. In crosstalk with the host immune system, the gut microbiota is able to modulate inflammation, insulin resistance, and intestinal permeability. Moreover, the composition of microbiota of an individual is a kind of fingerprint highly influenced by diet. In addition, not only the microbiota itself but also its metabolites influence the metabolism and host immune system. The gut microbiota can produce vitamins and a variety of nutrients including short-chain fatty acids. Holding a healthy balance of the microbiota is therefore highly important. In the present review, we discuss the impact of long-term intake of fructose on the composition of the intestinal microbiota and its biological consequences in regard to liver homeostasis and disease. In particular, we will refer about fructose-induced alterations of the tight junction proteins affecting the gut permeability, leading to the translocation of bacteria and bacterial endotoxins into the blood circulation.http://journal.frontiersin.org/article/10.3389/fimmu.2017.01159/fullfructosegut-liver-axisinulininsulin resistancemicrobiotaSCFA
collection DOAJ
language English
format Article
sources DOAJ
author Jessica Lambertz
Sabine Weiskirchen
Silvano Landert
Ralf Weiskirchen
spellingShingle Jessica Lambertz
Sabine Weiskirchen
Silvano Landert
Ralf Weiskirchen
Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
Frontiers in Immunology
fructose
gut-liver-axis
inulin
insulin resistance
microbiota
SCFA
author_facet Jessica Lambertz
Sabine Weiskirchen
Silvano Landert
Ralf Weiskirchen
author_sort Jessica Lambertz
title Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
title_short Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
title_full Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
title_fullStr Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
title_full_unstemmed Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
title_sort fructose: a dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2017-09-01
description Fructose is one of the key dietary catalysts in the development of non-alcoholic fatty liver disease (NAFLD). NAFLD comprises a complex disease spectrum, including steatosis (fatty liver), non-alcoholic steatohepatitis, hepatocyte injury, inflammation, and fibrosis. It is also the hepatic manifestation of the metabolic syndrome, which covers abdominal obesity, insulin resistance, dyslipidemia, glucose intolerance, or type 2 diabetes mellitus. Commensal bacteria modulate the host immune system, protect against exogenous pathogens, and are gatekeepers in intestinal barrier function and maturation. Dysbalanced intestinal microbiota composition influences a variety of NAFLD-associated clinical conditions. Conversely, nutritional supplementation with probiotics and preobiotics impacting composition of gut microbiota can improve the outcome of NAFLD. In crosstalk with the host immune system, the gut microbiota is able to modulate inflammation, insulin resistance, and intestinal permeability. Moreover, the composition of microbiota of an individual is a kind of fingerprint highly influenced by diet. In addition, not only the microbiota itself but also its metabolites influence the metabolism and host immune system. The gut microbiota can produce vitamins and a variety of nutrients including short-chain fatty acids. Holding a healthy balance of the microbiota is therefore highly important. In the present review, we discuss the impact of long-term intake of fructose on the composition of the intestinal microbiota and its biological consequences in regard to liver homeostasis and disease. In particular, we will refer about fructose-induced alterations of the tight junction proteins affecting the gut permeability, leading to the translocation of bacteria and bacterial endotoxins into the blood circulation.
topic fructose
gut-liver-axis
inulin
insulin resistance
microbiota
SCFA
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.01159/full
work_keys_str_mv AT jessicalambertz fructoseadietarysugarincrosstalkwithmicrobiotacontributingtothedevelopmentandprogressionofnonalcoholicliverdisease
AT sabineweiskirchen fructoseadietarysugarincrosstalkwithmicrobiotacontributingtothedevelopmentandprogressionofnonalcoholicliverdisease
AT silvanolandert fructoseadietarysugarincrosstalkwithmicrobiotacontributingtothedevelopmentandprogressionofnonalcoholicliverdisease
AT ralfweiskirchen fructoseadietarysugarincrosstalkwithmicrobiotacontributingtothedevelopmentandprogressionofnonalcoholicliverdisease
_version_ 1725599514894532608